TERT and hepatocellular carcinoma: Ribozyme: A number of trans-splicing ribozymes have been tested for RNAi therapeutic applications in HCC, many of which have targeted the elevated expression of telomerase reverse transcriptase (TERT) because of its role in promoting cell survival (112).